Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02953613 · ClinicalTrials.gov registry record
LipiScan- Ultrasound INterrogation of Atherosclerotic Coronary Arteries:
A clinical trial, sponsored by Corewell Health East.
- Terminated
- Registry status
- 7
- Enrollment target
NCT02953613 is a clinical trial that was terminated before completion, run by Corewell Health East. The registered enrollment target is 7 participants.
The verdict
NCT02953613 was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The goal of this study is to correlate both plaque and % lipid core content assessed by NIRS-IVUS (Imaging technique) to plaque burden and % lipid core content in coronary computerized tomographic angiography (CCTA) completed at 1 week in non-culprit coronary arteries.
Interventions
- DEVICE NIRS/IVUS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-04-28 |
| Est. Completion | 2017-11-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02953613
The ClinicalTrials.gov registry entry for NCT02953613 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NIRS/IVUS is the first listed.
NCT02953613 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02953613 about?
NCT02953613 is a clinical study titled "LipiScan- Ultrasound INterrogation of Atherosclerotic Coronary Arteries:". The goal of this study is to correlate both plaque and % lipid core content assessed by NIRS-IVUS (Imaging technique) to plaque burden and % lipid core content in coronary computerized tomographic angiography (CCTA) completed at 1 week in non-culprit coronary arteries.
What is the current status of trial NCT02953613?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2016-04-28. Estimated completion is 2017-11-20.
What interventions are being tested in trial NCT02953613?
The interventions under investigation include: NIRS/IVUS (DEVICE).
Who is sponsoring clinical trial NCT02953613?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.